These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8113982)

  • 1. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
    J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2.
    Jacobson PB; Schrier DJ
    J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
    Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
    Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
    Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
    Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
    Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
    Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.
    Tramposch KM; Chilton FH; Stanley PL; Franson RC; Havens MB; Nettleton DO; Davern LB; Darling IM; Bonney RJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):852-9. PubMed ID: 7965805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent.
    Daniels I; Lindsay MA; Keany CI; Burden RP; Fletcher J; Haynes AP
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):683-9. PubMed ID: 9729536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-step inactivation of bee venom phospholipase A2 by scalaradial.
    de Carvalho MS; Jacobs RS
    Biochem Pharmacol; 1991 Sep; 42(8):1621-6. PubMed ID: 1930288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.
    Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
    Winkler JD; Sung CM; Hubbard WC; Chilton FH
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2.
    Xie Y; Liu L; Huang X; Guo Y; Lou L
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1210-7. PubMed ID: 15923342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.
    Monti MC; Casapullo A; Cavasotto CN; Napolitano A; Riccio R
    Chembiochem; 2007 Sep; 8(13):1585-91. PubMed ID: 17691073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
    Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ
    Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
    Glaser KB; Carlson RP; Sung A; Bauer J; Lock YW; Holloway D; Sturm R; Hartman D; Walter T; Woeppel S
    Agents Actions; 1993; 39 Spec No():C30-2. PubMed ID: 8273577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
    Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
    Glaser KB; Lock YW; Chang JY
    Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.